| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ... Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017 | 5964 | 2017 |
| International scoring system for evaluating prognosis in myelodysplastic syndromes P Greenberg, C Cox, MM LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ... Blood, The Journal of the American Society of Hematology 89 (6), 2079-2088, 1997 | 5592 | 1997 |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ... Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010 | 4381 | 2010 |
| Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group F Rodeghiero, R Stasi, T Gernsheimer, M Michel, D Provan, DM Arnold, ... Blood, The Journal of the American Society of Hematology 113 (11), 2386-2393, 2009 | 3439 | 2009 |
| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3050 | 2003 |
| International consensus report on the investigation and management of primary immune thrombocytopenia D Provan, R Stasi, AC Newland, VS Blanchette, P Bolton-Maggs, ... Blood, The Journal of the American Society of Hematology 115 (2), 168-186, 2010 | 2790 | 2010 |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 2237 | 2017 |
| Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ... New England Journal of Medicine 376 (9), 836-847, 2017 | 1900 | 2017 |
| Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet MA Sanz, D Grimwade, MS Tallman, B Lowenberg, P Fenaux, EH Estey, ... Blood, The Journal of the American Society of Hematology 113 (9), 1875-1891, 2009 | 1205 | 2009 |
| Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial DJ Kuter, JB Bussel, RM Lyons, V Pullarkat, TB Gernsheimer, FM Senecal, ... The Lancet 371 (9610), 395-403, 2008 | 1092 | 2008 |
| A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute … P Fenaux, C Chastang, S Chevret, M Sanz, H Dombret, E Archimbaud, ... Blood, The Journal of the American Society of Hematology 94 (4), 1192-1200, 1999 | 976 | 1999 |
| Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA … MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ... Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000 | 826 | 2000 |
| Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA … MA Sanz, G Martín, M González, A León, C Rayón, C Rivas, D Colomer, ... Blood 103 (4), 1237-1243, 2004 | 621 | 2004 |
| Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ... Blood, The Journal of the American Society of Hematology 133 (15), 1630-1643, 2019 | 561 | 2019 |
| A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute … MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ... Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999 | 542 | 1999 |
| Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 … GF Sanz, MA Sanz, T Vallespi, MC Canizo, M Torrabadella, S Garcia, ... | 511 | 1989 |
| Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse M Levis, F Ravandi, ES Wang, MR Baer, A Perl, S Coutre, H Erba, ... Blood, The Journal of the American Society of Hematology 117 (12), 3294-3301, 2011 | 465 | 2011 |
| Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ... Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999 | 455 | 1999 |
| Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin J De La Serna, P Montesinos, E Vellenga, C Rayón, R Parody, A León, ... Blood, The Journal of the American Society of Hematology 111 (7), 3395-3402, 2008 | 442 | 2008 |
| Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia S De Botton, H Dombret, M Sanz, JS Miguel, D Caillot, R Zittoun, ... Blood, The Journal of the American Society of Hematology 92 (8), 2712-2718, 1998 | 440 | 1998 |
